Patents by Inventor Rochelle Witt

Rochelle Witt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and means for producing high titer, safe recombinant lentivirus vectors
    Patent number: 8846385
    Abstract: Lentiviral vectors modified at the 5? LTR or both the 5? and 3? LTR's are useful in the production of recombinant lentivirus vectors. Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production.
    Type: Grant
    Filed: July 26, 2006
    Date of Patent: September 30, 2014
    Assignee: GBP IP, LLC
    Inventors: Luigi Naldini, Thomas Dull, Deborah A. Farson, Rochelle Witt
  • Method and means for producing high titer, safe, recombinant lentivirus vectors
    Patent number: 8652837
    Abstract: Lentiviral vectors modified at the 5? LTR or both the 5? and 3? LTR are useful in the production of recombinant lentivirus vectors (See the Figure). Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production. The vectors can contain inducible or conditional promoters.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: February 18, 2014
    Assignee: GBP IP, LLC
    Inventors: Luigi Naldini, Thomas Dull, Anatoly Bukovsky, Deborah A. Farson, Rochelle Witt
  • METHOD AND MEANS FOR PRODUCING HIGH TITER, SAFE RECOMBINANT LENTIVIRUS VECTORS
    Publication number: 20080286836
    Abstract: Lentiviral vectors modified at the 5? LTR or both the 5? and 3? LTR's are useful in the production of recombinant lentivirus vectors. Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production.
    Type: Application
    Filed: July 26, 2006
    Publication date: November 20, 2008
    Applicant: Cell Genesys, Inc.
    Inventors: Luigi Naldini, Thomas Dull, Deborah A. Farson, Rochelle Witt
  • METHOD AND MEANS FOR PRODUCING HIGH TITER, SAFE, RECOMBINANT LENTIVIRUS VECTORS
    Publication number: 20080241929
    Abstract: Lentiviral vectors modified at the 5? LTR or both the 5? and 3? LTR are useful in the production of recombinant lentivirus vectors (See the Figure). Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production. The vectors can contain inducible or conditional promoters.
    Type: Application
    Filed: July 20, 2007
    Publication date: October 2, 2008
    Applicant: Cell Genesys, Inc.
    Inventors: Luigi Naldini, Thomas Dull, Anatoly Bukovsky, Deborah Farson, Rochelle Witt
  • Method and means for producing high titer, safe, recombinant lentivirus vectors
    Patent number: 7250299
    Abstract: Lentiviral vectors modified at the 5? LTR or both the 5? and 3? LTR are useful in the production of recombinant lentivirus vectors (See the Figure). Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production. The vectors can contain inducible or conditional promoters.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: July 31, 2007
    Assignee: Cell Genesys, Inc.
    Inventors: Luigi Naldini, Thomas Dull, Anatoly Bukovsky, Deborah Farson, Rochelle Witt
  • Method and means for producing high titer, safe, recombinant lentivirus vectors
    Patent number: 7083981
    Abstract: Lentiviral vectors modified at the 5? LTR or both the 5? and 3? LTR's are useful in the production of recombinant lentivirus vectors. Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: August 1, 2006
    Assignee: Cell Genesys, Inc.
    Inventors: Luigi Naldini, Thomas Dull, Deborah A. Farson, Rochelle Witt
  • Method and means for producing high titer, safe, recombinant lentivirus vectors
    Publication number: 20050255597
    Abstract: Lentiviral vectors modified at the 5? LTR or both the 5? and 3? LTR's are useful in the production of recombinant lentivirus vectors. Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production.
    Type: Application
    Filed: July 21, 2005
    Publication date: November 17, 2005
    Inventors: Luigi Naldini, Thomas Dull, Deborah Farson, Rochelle Witt
  • Method and means for producing high titer, safe, recombinant lentivirus vectors
    Patent number: 6924144
    Abstract: Lentiviral vectors modified at the 5? LTR or both the 5? and 3? LTR's are useful in the production of recombinant lentivirus vectors. Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: August 2, 2005
    Assignee: Cell Genesys, Inc.
    Inventors: Luigi Naldini, Thomas Dull, Deborah A. Farson, Rochelle Witt
  • Method and means for producing high titer, safe, recombinant lentivirus vectors
    Publication number: 20020173030
    Abstract: Lentiviral vectors modified at the 5′ LTR or both the 5′ and 3′ LTR's are useful in the production of recombinant lentivirus vectors. Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production.
    Type: Application
    Filed: July 10, 2002
    Publication date: November 21, 2002
    Applicant: Cell Genesys, Inc.
    Inventors: Luigi Naldini, Thomas Dull, Deborah A. Farson, Rochelle Witt
  • Method and means for producing high titer, safe, recombinant lentivirus vectors
    Patent number: 6428953
    Abstract: Lentiviral vectors modified at the 5′ LTR or both the 5′ and 3′ LTR's are useful in the production of recombinant lentivirus vectors. Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production.
    Type: Grant
    Filed: June 26, 2000
    Date of Patent: August 6, 2002
    Assignee: Cell Genesys, Inc.
    Inventors: Luigi Naldini, Thomas Dull, Deborah A. Farson, Rochelle Witt
  • Method and means for producing high titer, safe, recombinant lentivirus vectors
    Patent number: 6165782
    Abstract: Lentiviral vectors modified at the 5' LTR or both the 5' and 3' LTR's are useful in the production of recombinant lentivirus vectors. Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production.
    Type: Grant
    Filed: March 18, 1999
    Date of Patent: December 26, 2000
    Assignee: Cell Genesys, Inc.
    Inventors: Luigi Naldini, Thomas Dull, Deborah A. Farson, Rochelle Witt
  • Method and means for producing high titer, safe, recombinant lentivirus vectors
    Patent number: 5994136
    Abstract: Lentiviral vectors modified at the 5' LTR or both the 5' and 3' LTR's are useful in the production of recombinant lentivirus vectors. Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: November 30, 1999
    Assignee: Cell Genesys, Inc.
    Inventors: Luigi Naldini, Thomas Dull, Deborah A. Farson, Rochelle Witt